Visual hallucinations in Parkinson's disease: Clues to separate origins

[1]  Enrico Marchioni,et al.  Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[2]  David R Williams,et al.  Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study , 2005, The Lancet Neurology.

[3]  S. Papapetropoulos,et al.  Factors associated with drug–induced visual hallucinations in Parkinson's disease , 2005, Journal of Neurology.

[4]  M. Oda,et al.  The Relation Between Visual Hallucinations and Visual Evoked Potential in Parkinson Disease , 2005, Clinical neuropharmacology.

[5]  G. Fénelon,et al.  Hallucinations in Parkinson's disease: A follow‐up study , 2005, Movement disorders : official journal of the Movement Disorder Society.

[6]  G. Stebbins,et al.  Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model , 2005, Movement disorders : official journal of the Movement Disorder Society.

[7]  C. Peretz,et al.  Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson’s disease , 2004, Journal of Neural Transmission.

[8]  M. Boggild,et al.  Charles Bonnet syndrome—elderly people and visual hallucinations , 2004, BMJ : British Medical Journal.

[9]  D. Calne,et al.  Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model. , 2004, Brain : a journal of neurology.

[10]  M. Onofrj,et al.  Severe worsening of parkinsonism in Lewy body dementia due to donepezil , 2003, Neurology.

[11]  A. Destée,et al.  Retinal involvement in dementia with Lewy bodies: A clue to hallucinations? , 2003, Annals of neurology.

[12]  W. Poewe Psychosis in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[13]  G. Ebersbach An artist's view of drug‐induced hallucinosis , 2003, Movement disorders : official journal of the Movement Disorder Society.

[14]  Yuichi Inoue,et al.  Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[15]  M. Onofrj,et al.  HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[16]  M. Onofrj,et al.  Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism , 2003, Neurology.

[17]  M. Rossor,et al.  “—but who is that on the other side of you?” Extracampine hallucinations revisited , 2002, The Lancet.

[18]  W. Burke,et al.  The neural basis of Charles Bonnet hallucinations: a hypothesis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[19]  M. Onofrj,et al.  Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up , 2002, Neurological Sciences.

[20]  A. Korczyn Hallucinations in Parkinson's disease , 2001, The Lancet.

[21]  F. Provini,et al.  Agrypnia excitata: clinical features and pathophysiological implications. , 2001, Sleep medicine reviews.

[22]  A. David,et al.  Visual hallucinations in Parkinson's disease: a review and phenomenological survey , 2001, Journal of neurology, neurosurgery, and psychiatry.

[23]  D. Joel,et al.  Open interconnected model of basal ganglia‐thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[24]  A. Husain,et al.  REM Sleep Behavior Disorder: Potential Relationship to Post-traumatic Stress Disorder , 2001, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[25]  R. Stickgold,et al.  Dreaming and the brain: Toward a cognitive neuroscience of conscious states , 2000, Behavioral and Brain Sciences.

[26]  Y. Agid,et al.  Hallucinations, REM sleep, and Parkinson’s disease , 2000, Neurology.

[27]  G. Fénelon,et al.  Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. , 2000, Brain : a journal of neurology.

[28]  R. Raman,et al.  Decreased color discrimination and contrast sensitivity in Parkinson’s disease , 2000, Journal of the Neurological Sciences.

[29]  I. Anjegård,et al.  [Two cases of peduncular hallucinosis. Vivid, colorful and dancing images and figures]. , 1999, Lakartidningen.

[30]  S. Leurgans,et al.  Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.

[31]  S. Leurgans,et al.  Poor visual discrimination and visual hallucinations in Parkinson's disease. , 1998, Clinical neuropharmacology.

[32]  Y. Inoue,et al.  Night‐time hypnopompic visual hallucinations related to REM sleep disorder , 1998, Psychiatry and clinical neurosciences.

[33]  R. Grünewald,et al.  Hallucinosis in idiopathic Parkinson’s disease , 1997, Journal of neurology, neurosurgery, and psychiatry.

[34]  Karl J. Friston,et al.  Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia , 1995, Nature.

[35]  R. Teunisse,et al.  The Charles Bonnet Syndrome: A Large Prospective Study in the Netherlands , 1995, British Journal of Psychiatry.

[36]  R. de la Fuente Fernández,et al.  Peduncular hallucinosis and right hemiparkinsonism caused by left mesencephalic infarction. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[37]  C. Tanner,et al.  Polysomnographic sleep measures in Parkinson's disease patients with treatment‐induced hallucinations , 1993, Annals of neurology.

[38]  R. Melzack,et al.  Visual Hallucinations and Mental State: A Study of 14 Charles Bonnet Syndrome Hallucinators , 1993, The Journal of nervous and mental disease.

[39]  M. Onofrj,et al.  Narcolepsy associated with primary temporal lobe B-cells lymphoma in a HLA DR2 negative subject. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[40]  T. Di Paolo,et al.  Decreased dopamine in the retinas of patients with Parkinson's disease. , 1990, Investigative ophthalmology & visual science.

[41]  D. Levine,et al.  Peduncular hallucinosis associated with isolated infarction of the substantia nigra pars reticulata , 1990, Annals of neurology.

[42]  J. Saint-Cyr,et al.  Procedural learning and neostriatal dysfunction in man. , 1988, Brain : a journal of neurology.

[43]  M. Ghilardi,et al.  Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. , 1988, Brain : a journal of neurology.

[44]  N. Swerdlow,et al.  Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striatopallido-thalamic function , 1987, Behavioral and Brain Sciences.

[45]  M. Ghilardi,et al.  Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[46]  M W Mahowald,et al.  Chronic behavioral disorders of human REM sleep: a new category of parasomnia. , 1986, Sleep.

[47]  M. Onofrj,et al.  Dopaminergic deficiency causes delayed visual evoked potentials in rats , 1982, Annals of neurology.

[48]  C. Goetz,et al.  Pharmacology of hallucinations induced by long-term drug therapy. , 1982, The American journal of psychiatry.

[49]  M. Onofrj,et al.  SYSTEM DISEASES AND VISUAL EVOKED POTENTIAL DIAGNOSIS IN NEUROLOGY: CHANGES DUE TO SYNAPTIC MALFUNCTION * , 1980, Annals of the New York Academy of Sciences.

[50]  M. Yahr,et al.  Measurements of visual evoked potentials in Parkinson's disease. , 1978, Brain : a journal of neurology.

[51]  H. Klawans,et al.  Levodopa-induced psychosis: a kindling phenomenon. , 1978, The American journal of psychiatry.

[52]  J. Feigenson,et al.  Mental symptoms in Parkinson's disease during chronic treatment with levodopa , 1976, Neurology.

[53]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[54]  R. Harper,et al.  Coloured Lilliputian Hallucinations with Amantadine , 1973, The Medical journal of Australia.

[55]  O. Sacks,et al.  Effects of levodopa in parkinsonian patients with dementia , 1972, Neurology.

[56]  A. Damasio,et al.  Psychiatric aspects in Parkinsonism treated with L-dopa , 1971, Journal of neurology, neurosurgery, and psychiatry.

[57]  G. Celesia,et al.  Psychosis and other psychiatric manifestations of levodopa therapy. , 1970, Archives of neurology.

[58]  D. Ross,et al.  Mental Symptoms in Parkinsonism following Benzhexol Hydrochloride Therapy , 1956, British medical journal.

[59]  W. Kuhn,et al.  Effects of apomorphine on visual functions in Parkinson's disease , 2000, Journal of Neural Transmission.

[60]  M. Tagliati,et al.  The visual system in Parkinson's disease. , 1993, Advances in neurology.

[61]  M. Mahowald,et al.  Status dissociatus--a perspective on states of being. , 1991, Sleep.

[62]  W. Weiner,et al.  Sleep disorders and sleep effect in Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.

[63]  M. Ghilardi,et al.  Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates. , 1988, Life sciences.

[64]  S. Fahn Unified Parkinson's Disease Rating Scale , 1987 .

[65]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[66]  P. Rondot,et al.  Mental disorders in Parkinson's disease after treatment with L-DOPA. , 1984, Advances in neurology.